Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Luis Cabrera

Showing results (101-110 of 129) with videos related to

Pageof 13
Sort By:
International Microbiology : the Official Journal of the Spanish Society for Microbiology|June 29, 2021
Tec1, a member of the TEA transcription factors family, is involved in virulence and basidiocarp development in Ustilago maydisClaudia Geraldine León-Ramírez, José Alejandro Sánchez-Arreguin, José Luis Cabrera-Ponce, et al.
Cancer Treatment and Research Communications|April 17, 2026
Progression phenotypes to anti-PD-(L)1 therapy and subsequent management of patients with metastatic NSCLC: A real-world cohort studyEnrique Caballé-Pérez, Luis Cabrera-Miranda, David Dávila-Dupont, et al.
Lung Cancer (Amsterdam, Netherlands)|March 20, 2019
Radical consolidative treatment provides a clinical benefit and long-term survival in patients with synchronous oligometastatic non-small cell lung cancer: A phase II studyOscar Arrieta, Feliciano Barrón, Federico Maldonado, et al.
Journal of Clinical Microbiology|October 30, 2015
Microscopic Observation Drug Susceptibility Assay for Rapid Diagnosis of Lymph Node Tuberculosis and Detection of Drug ResistanceDaniela E Kirwan, Cesar Ugarte-Gil, Robert H Gilman, et al.
Nature Communications|December 12, 2025
Author Correction: Alectinib in combination with bevacizumab as first-line treatment in ALK-rearranged non-small cell lung cancer (ALEK-B): a single-arm, phase 2 trialOscar Arrieta, Luis Lara-Mejía, Eduardo Rios-Garcia, et al.
Communications Biology|January 9, 2025
Shaping current European mitochondrial haplogroup frequency in response to infection: the case of SARS-CoV-2 severityJosé Luis Cabrera-Alarcon, Raquel Cruz, Marina Rosa-Moreno, et al.
Frontiers in Oncology|December 19, 2023
PD-L1 expression complements CALGB prognostic scoring system in malignant pleural mesotheliomaAlejandro Avilés-Salas, Luis Cabrera-Miranda, Norma Hernández-Pedro, et al.
Plant Science : an International Journal of Experimental Plant Biology|February 2, 2023
CRISPRa-mediated transcriptional activation of the SlPR-1 gene in edited tomato plantsLeonardo García-Murillo, Eliana Valencia-Lozano, Nicolás Alberto Priego-Ranero, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|March 14, 2026
Long‑term outcomes of prophylactic cranial irradiation in high‑risk metastatic NSCLC: Final PRoT‑BM analysisLuis Cabrera-Miranda, Federico Maldonado, Eduardo Rios-Garcia, et al.
BMC Cancer|April 3, 2026
Clinical, diagnostic and prognostic relevance of GATA3 in malignant pleural mesothelioma: a retrospective cohort studyAlejandro Avilés-Salas, David Dávila Dupont, Alejandro Aranda-Gutierrez, et al.
Pageof 13

Showing results (101-110 of 129) with videos related to

Sort By:
Pageof 13
International Microbiology : the Official Journal of the Spanish Society for Microbiology|June 29, 2021
Tec1, a member of the TEA transcription factors family, is involved in virulence and basidiocarp development in Ustilago maydisClaudia Geraldine León-Ramírez, José Alejandro Sánchez-Arreguin, José Luis Cabrera-Ponce, et al.
Cancer Treatment and Research Communications|April 17, 2026
Progression phenotypes to anti-PD-(L)1 therapy and subsequent management of patients with metastatic NSCLC: A real-world cohort studyEnrique Caballé-Pérez, Luis Cabrera-Miranda, David Dávila-Dupont, et al.
Lung Cancer (Amsterdam, Netherlands)|March 20, 2019
Radical consolidative treatment provides a clinical benefit and long-term survival in patients with synchronous oligometastatic non-small cell lung cancer: A phase II studyOscar Arrieta, Feliciano Barrón, Federico Maldonado, et al.
Journal of Clinical Microbiology|October 30, 2015
Microscopic Observation Drug Susceptibility Assay for Rapid Diagnosis of Lymph Node Tuberculosis and Detection of Drug ResistanceDaniela E Kirwan, Cesar Ugarte-Gil, Robert H Gilman, et al.
Nature Communications|December 12, 2025
Author Correction: Alectinib in combination with bevacizumab as first-line treatment in ALK-rearranged non-small cell lung cancer (ALEK-B): a single-arm, phase 2 trialOscar Arrieta, Luis Lara-Mejía, Eduardo Rios-Garcia, et al.
Communications Biology|January 9, 2025
Shaping current European mitochondrial haplogroup frequency in response to infection: the case of SARS-CoV-2 severityJosé Luis Cabrera-Alarcon, Raquel Cruz, Marina Rosa-Moreno, et al.
Frontiers in Oncology|December 19, 2023
PD-L1 expression complements CALGB prognostic scoring system in malignant pleural mesotheliomaAlejandro Avilés-Salas, Luis Cabrera-Miranda, Norma Hernández-Pedro, et al.
Plant Science : an International Journal of Experimental Plant Biology|February 2, 2023
CRISPRa-mediated transcriptional activation of the SlPR-1 gene in edited tomato plantsLeonardo García-Murillo, Eliana Valencia-Lozano, Nicolás Alberto Priego-Ranero, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|March 14, 2026
Long‑term outcomes of prophylactic cranial irradiation in high‑risk metastatic NSCLC: Final PRoT‑BM analysisLuis Cabrera-Miranda, Federico Maldonado, Eduardo Rios-Garcia, et al.
BMC Cancer|April 3, 2026
Clinical, diagnostic and prognostic relevance of GATA3 in malignant pleural mesothelioma: a retrospective cohort studyAlejandro Avilés-Salas, David Dávila Dupont, Alejandro Aranda-Gutierrez, et al.
Pageof 13